|
|
||||||||||
|
J Am Coll Cardiol, 2003; 42:652-658, doi:10.1016/S0735-1097(03)00783-6 © 2003 by the American College of Cardiology Foundation |

* Division of Cardiology, Department of Medicine, University of Oulu, Oulu, Finland
Division of Cardiology, University of Miami, Miami, Florida, USA
Manuscript received December 20, 2002; revised manuscript received February 14, 2003, accepted March 20, 2003.
* Reprint requests and correspondence: Dr. Heikki V. Huikuri, Professor of Medicine. Division of Cardiology, Department of Internal Medicine, University of Oulu, P.O. Box 5000, FIN-90014, Oulu, Finland.
heikki.huikuri{at}oulu.fi
OBJECTIVES: This study assessed the predictive power of arrhythmia risk markers after an acute myocardial infarction (AMI).
BACKGROUND: Several risk variables have been suggested to predict the occurrence of sudden cardiac death (SCD), but the utility of these variables has not been well established among patients using medical therapy according to contemporary guidelines.
METHODS: A consecutive series of 700 patients with AMI was studied. The end points were total mortality, SCD, and nonsudden cardiac death (non-SCD). Nonsustained ventricular tachycardia (nsVT), ejection fraction (EF), heart rate variability, baroreflex sensitivity, signal-averaged electrocardiogram (SAECG), QT dispersion, and QRS duration were analyzed (n = 675). Beta-blocking therapy was used by 97% of the patients at discharge and by 95% at one and two years after AMI.
RESULTS: During a mean (±SD) follow-up of 43 ± 15 months, 37 non-SCDs (5.5%) and 22 SCDs (3.2%) occurred. All arrhythmia risk variables differed between the survivors and those with non-SCD (e.g., the standard deviation of N-N intervals was 98 ± 32 vs. 74 ± 21 ms [p < 0.001] and the QRS duration was 103 ± 22 vs.89 ± 16 ms [p < 0.001]). Sudden cardiac death was weakly predicted only by reduced EF (<0.40; p < 0.05), nsVT (p < 0.05), and abnormal SAECG (p < 0.05), but not by autonomic markers or standard ECG variables. The positive predictive accuracy of EF, nsVT, and abnormal SAECG as predictors of SCD was relatively low (8%, 12%, and 13%, respectively).
CONCLUSIONS: The common arrhythmia risk variables, particularly the autonomic and standard ECG markers, have limited predictive power in identifying patients at risk of SCD after AMI in the beta-blocking era.
| ||||||||||||||||||||||
This article has been cited by other articles:
![]() |
L. Ding, W. Hua, H. Niu, K. Chen, and S. Zhang Primary prevention of sudden cardiac death using implantable cardioverter defibrillators Europace, September 1, 2008; 10(9): 1034 - 1041. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention J. Am. Coll. Cardiol., August 25, 2008; (2008) j.jacc.2008.05.003v1. [Full Text] [PDF] |
||||
![]() |
H. S. Lim, G. Y.H. Lip, and H.-F. Tse Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule Europace, May 1, 2008; 10(5): 536 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Gibson, Y. B. Pride, J. L. Buros, E. Lord, A. Shui, S. A. Murphy, D. S. Pinto, P. J. Zimetbaum, M. S. Sabatine, C. P. Cannon, et al. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol., February 5, 2008; 51(5): 546 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Exner, K. M. Kavanagh, M. P. Slawnych, L. B. Mitchell, D. Ramadan, S. G. Aggarwal, C. Noullett, A. Van Schaik, R. T. Mitchell, M. A. Shibata, et al. Noninvasive Risk Assessment Early After a Myocardial Infarction: The REFINE Study J. Am. Coll. Cardiol., December 11, 2007; 50(24): 2275 - 2284. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Bunch, S. H. Hohnloser, and B. J. Gersh Mechanisms of Sudden Cardiac Death in Myocardial Infarction Survivors: Insights From the Randomized Trials of Implantable Cardioverter-Defibrillators Circulation, May 8, 2007; 115(18): 2451 - 2457. [Full Text] [PDF] |
||||
![]() |
J. J. Bailey, M. Hodges, and T. R. Church Decision to Implant a Cardioverter Defibrillator after Myocardial Infarction: The Role of Ejection Fraction v. Other Risk Factor Markers Med Decis Making, March 1, 2007; 27(2): 151 - 160. [Abstract] [PDF] |
||||
![]() |
D. E. Hofsten, K. Wachtell, B. Lund, H. Molgaard, K. Egstrup, and on behalf of the DANAMI-2 Investigators Prevalence and prognostic implications of non-sustained ventricular tachycardia in ST-segment elevation myocardial infarction after revascularization with either fibrinolysis or primary angioplasty Eur. Heart J., February 2, 2007; 28(4): 407 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Solomon, S. Zelenkofske, J. J.V. McMurray, P. V. Finn, E. Velazquez, G. Ertl, A. Harsanyi, J. L. Rouleau, A. Maggioni, L. Kober, et al. Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both N. Engl. J. Med., June 23, 2005; 352(25): 2581 - 2588. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Buxton Sudden Death after Myocardial Infarction -- Who Needs Prophylaxis, and When? N. Engl. J. Med., June 23, 2005; 352(25): 2638 - 2640. [Full Text] [PDF] |
||||
![]() |
A. E. Buxton, A. J. Moss, A. E. Buxton, and A. J. Moss Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Circulation, May 17, 2005; 111(19): 2537 - 2549. [Full Text] [PDF] |
||||
![]() |
A. Bauer, P. Guzik, P. Barthel, R. Schneider, K. Ulm, M. A. Watanabe, and G. Schmidt Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era Eur. Heart J., April 2, 2005; 26(8): 755 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Makikallio, P. Barthel, R. Schneider, A. Bauer, J. M. Tapanainen, M. P. Tulppo, G. Schmidt, and H. V. Huikuri Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era Eur. Heart J., April 2, 2005; 26(8): 762 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Lee and C.-P. Lau The use of signal-averaged electrocardiogram in risk stratification after acute myocardial infarction in the modern era Eur. Heart J., April 2, 2005; 26(8): 747 - 748. [Full Text] [PDF] |
||||
![]() |
N. H.M. Kupper, G. Willemsen, M. van den Berg, D. de Boer, D. Posthuma, D. I. Boomsma, and E. J.C. de Geus Heritability of Ambulatory Heart Rate Variability Circulation, November 2, 2004; 110(18): 2792 - 2796. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Kiviniemi, A. J. Hautala, T. Seppanen, T. H. Makikallio, H. V. Huikuri, and M. P. Tulppo Saturation of high-frequency oscillations of R-R intervals in healthy subjects and patients after acute myocardial infarction during ambulatory conditions Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1921 - H1927. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Haigney, W. Zareba, P. J. Gentlesk, R. E. Goldstein, M. Illovsky, S. McNitt, M. L. Andrews, A. J. Moss, and the MADIT II Investigators QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1481 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Thygesen and B. F Uretsky Acute ischaemia as a trigger of sudden cardiac death Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D88 - D90. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G Katritsis and A.J. Camm Nonsustained ventricular tachycardia: where do we stand? Eur. Heart J., July 1, 2004; 25(13): 1093 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Tapanainen, K. S. Lindgren, T. H. Makikallio, O. Vuolteenaho, J. Leppaluoto, and H. V. Huikuri Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era J. Am. Coll. Cardiol., March 3, 2004; 43(5): 757 - 763. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |